PaperS7610
Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity
The authors report JUN-associated changes in lung fibroblasts and test mechanisms and interventions in engineered cultures and mouse models. Eleven end-stage cases and three cancer-resection controls define the human comparison. Preclinical findings, sampling biases and explicit toxicity cautions prevent claims of proven treatment benefit or safety in patients.
Complete supplied main text; bounded supplemental visuals